Guidelines For Abstract Submission

• The abstract submitted should be relevant to the theme of the conference.
• The abstract must represent a completed research study. Submissions of research proposals or ongoing projects are not eligible.
• The abstract submitted must not have been previously presented at any conference.
• The abstract should not exceed 250 words, including headings and body text.
• The title should be reflective of the study, intervention, or program. It should be concise and in sentence case (not all caps).
• Include the full names of all authors and specify their affiliations (institution, department, city).
• Briefly describe the context or rationale for the study in the introduction or background.
• Clearly state the purpose or aim of the research in the objective.
• Outline key methods, designs, and tools used in the study.
• Highlight main findings or expected outcomes in the results section. Use concise language and avoid detailed tables or figures in the abstract.
• State the implications or significance of the research in the conclusion.
Abstract Formatting
• Use Calibri font, 12-point size, and single spacing.
• Write in clear, concise English and avoid jargon, abbreviations, or undefined acronyms.
• Maintain 1-inch margins on all sides.
• Submit the abstract in Word or PDF format.

Research Areas:
• Drug Discovery & Development
• Pharmaceutical Technology & Nanomedicine
• Clinical Pharmacy & Pharmacy Practice
• Pharmacology & Toxicology
• Biotechnology & Biopharmaceutics
• Regulatory Affairs & Pharmacovigilance
• Herbal and Natural Products
• Recent Trends (AI) in Pharmacy Education and Research

Abstract submission at: [email protected]
Abstract Submission Deadline: 15 Sep, 2025